Skip to main content
. 2018 Nov 13;12:2413–2424. doi: 10.2147/PPA.S182563

Figure 2.

Figure 2

Reduction in number of migraine headache days per month in patients with episodic migraine (A) and chronic migraine (B).

Notes: Results are LS mean change from baseline ± SE. ^p<0.001; **p<0.01.

Abbreviations: GMB, galcanezumab; LS, least square; SE, standard error.